Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 3 |
NetGPI | no | yes: 0, no: 3 |
Related structures:
AlphaFold database: A4I2T2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 131 | 137 | PF00089 | 0.712 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.529 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.716 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 100 | 102 | PF00082 | 0.716 |
DOC_MAPK_DCC_7 | 28 | 36 | PF00069 | 0.516 |
DOC_MAPK_gen_1 | 134 | 144 | PF00069 | 0.629 |
DOC_MAPK_MEF2A_6 | 28 | 36 | PF00069 | 0.516 |
DOC_MAPK_MEF2A_6 | 71 | 78 | PF00069 | 0.642 |
DOC_WW_Pin1_4 | 153 | 158 | PF00397 | 0.682 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.611 |
LIG_14-3-3_CanoR_1 | 120 | 127 | PF00244 | 0.652 |
LIG_14-3-3_CanoR_1 | 152 | 157 | PF00244 | 0.681 |
LIG_14-3-3_CanoR_1 | 24 | 32 | PF00244 | 0.472 |
LIG_BRCT_BRCA1_1 | 118 | 122 | PF00533 | 0.764 |
LIG_deltaCOP1_diTrp_1 | 115 | 122 | PF00928 | 0.756 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.507 |
LIG_FHA_2 | 154 | 160 | PF00498 | 0.685 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.655 |
LIG_FHA_2 | 87 | 93 | PF00498 | 0.681 |
LIG_SH2_PTP2 | 33 | 36 | PF00017 | 0.515 |
LIG_SH2_STAP1 | 83 | 87 | PF00017 | 0.640 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.620 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.624 |
LIG_TYR_ITIM | 31 | 36 | PF00017 | 0.510 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.735 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.636 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.679 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.629 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.496 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.546 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.707 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.435 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.624 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.426 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.547 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.627 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.756 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.561 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.680 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.568 |
MOD_NEK2_1 | 12 | 17 | PF00069 | 0.517 |
MOD_PKA_1 | 100 | 106 | PF00069 | 0.716 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.716 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.705 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.501 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.524 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.653 |
MOD_PKB_1 | 118 | 126 | PF00069 | 0.751 |
MOD_PKB_1 | 150 | 158 | PF00069 | 0.681 |
MOD_ProDKin_1 | 153 | 159 | PF00069 | 0.685 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.610 |
TRG_DiLeu_BaEn_2 | 62 | 68 | PF01217 | 0.689 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.515 |
TRG_ER_diArg_1 | 117 | 120 | PF00400 | 0.756 |
TRG_ER_diArg_1 | 141 | 144 | PF00400 | 0.622 |
TRG_ER_diArg_1 | 145 | 148 | PF00400 | 0.621 |
TRG_ER_diArg_1 | 149 | 152 | PF00400 | 0.596 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IPX1 | Leishmania donovani | 100% | 100% |
E9ADB0 | Leishmania major | 87% | 100% |